The MonarchE trial: improving the clinical outcome in HR<sup>+</sup>/HER2<sup>−</sup> early breast cancer: recent results and next steps-Reference-Cited by-同舟云学术

The MonarchE trial: improving the clinical outcome in HR⁺/HER2⁻ early breast cancer: recent results and next steps

Published:2023-07-18 Issue:8 Volume:43 Page:938-942
ISSN:2523-3548
Container-title:Cancer Communications
language:en
Short-container-title:Cancer Communications

Author:

Bertucci François¹²^ORCID,Finetti Pascal¹,Mamessier Emilie¹,De Nonneville Alexandre¹²

Affiliation:

1. Laboratory of Predictive Oncology Cancer Research Center of Marseille Paoli‐Calmettes Institute Aix‐Marseille University, INSERM UMR1068, CNRS UMR725, Team Labelled “Ligue contre le cancer” Marseille France

2. Department of Medical Oncology Paoli‐Calmettes Institute Marseille France

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cac2.12466

Reference10 articles.

1. Definition of High-Risk Early Hormone-Positive HER2−Negative Breast Cancer: A Consensus Review

2. Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03)

3. Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer—The Penelope-B Trial

4. Abemaciclib plus endocrine therapy for hormone receptor-positive, HER2-negative, node-positive, high-risk early breast cancer (monarchE): results from a preplanned interim analysis of a randomised, open-label, phase 3 trial

5. NATALEE: Phase III study of ribociclib (RIBO) + endocrine therapy (ET) as adjuvant treatment in hormone receptor–positive (HR+), human epidermal growth factor receptor 2–negative (HER2–) early breast cancer (EBC).

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Can a combination of probiotics and nutraceuticals help preventing the abemaciclib-related diarrhea in breast cancer patients?;Minerva Gastroenterology;2024-05

2. Breast cancer in Adolescent & Young Adult (AYA) has a specific biology and poor patient outcome compared to older patients;2024-03-25

3. Somatic Mutations in Latin American Breast Cancer Patients: A Systematic Review and Meta-Analysis;Diagnostics;2024-01-29